Sanofi Offloads Two German OTC Brands, New CEO Prepares To Make Mark

04 Sep 2019

Sanofi's push to concentrate its Consumer Healthcare portfolio on priority categories sees it offload two OTC brands in Germany and Austria. Meanwhile, new Sanofi CEO Paul Hudson has spoken about his intention to review the firm's plans in the OTC market.

A professional businessman thinking while standing on a black arrow pointing forward in grey space concept

Sanofi has divested two OTC brands to Italy’s Angelini SPA in a deal worth €47m ($51m). The French firm signaled earlier this year that it would continue to rationalize its Consumer Healthcare portfolio to focus its efforts around a number of priority brands and categories. (Also see "Sanofi Plans Further Consumer Health Divestments As It Reports Slow Start To Year" - HBW Insight, 29 April, 2019.)

Angelini has picked up the BoxaGrippal (ibuprofen/pseudoephedrine) cold and flu brand and the Heumann range of medicinal teas indicated to...